2012
DOI: 10.1007/s00192-012-1790-3
|View full text |Cite
|
Sign up to set email alerts
|

Robot-assisted surgery:—impact on gynaecological and pelvic floor reconstructive surgery

Abstract: The da Vinci Surgical System dominates robotic surgery, as the only robotic device to have FDA approval in gynaecology. The benefits of robot-assisted surgery include decreased length of stay, decreased blood loss and analgesic requirements. Ergonomic improvements allow the surgeon to operate with less risk of neck and back injury. Unfortunately the initial economic impact of purchasing and maintaining a robot are great but must be balanced with the potential savings from reduced length of stay and earlier ret… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 84 publications
0
9
0
Order By: Relevance
“…Until now, two more models have been developed: first, the da Vinci S High Definition Surgical System, which has improved visual capabilities, and subsequently, the da Vinci Si Surgical System, which allows for dual-console capabilities. It also contains enhanced high-definition three-dimensional vision with an interface [3].…”
Section: The Da Vinci Surgical Systemmentioning
confidence: 99%
“…Until now, two more models have been developed: first, the da Vinci S High Definition Surgical System, which has improved visual capabilities, and subsequently, the da Vinci Si Surgical System, which allows for dual-console capabilities. It also contains enhanced high-definition three-dimensional vision with an interface [3].…”
Section: The Da Vinci Surgical Systemmentioning
confidence: 99%
“…An increased operating time when compared with laparotomy also adds to the cost. The additional cost for a robotic hysterectomy compared with laparoscopic hysterectomy has been quoted as approximately $2600; this difference is lower for oncological procedures . Comparative figures between different countries cannot be used as the reimbursement rates are calculated differently in different areas.…”
Section: Costmentioning
confidence: 99%
“…Similar to other approaches, there is no recommendation regarding minimally invasive surgery and the use of NOACs. Robotassisted surgery is associated with increased ergonomic benefits for the surgeon, decreased length of hospital stay and less blood loss [25]; similarly, there is no recommendation regarding NOACs in robotic surgery.…”
Section: Minimally Invasive Approachmentioning
confidence: 99%